Curi Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-159
Closed -$5K – 221
2022
Q2
$5K Hold
159
– – ﹤0.01% 444
2022
Q1
$7K Hold
159
– – ﹤0.01% 385
2021
Q4
$9K Buy
+159
New +$11K ﹤0.01% 325
2021
Q1
– Sell
-98
Closed -$9K – 121
2020
Q4
$9K Buy
+98
New +$7.81K 0.01% 258

Other funds holding ARKG

Curi Wealth Management's ARKG Position: Q3 2022 in Review

Curi Wealth Management sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2022, closing a stake of 159 shares — an estimated $5K sold.

Curi Wealth Management first reported a position in ARKG in Q4 2020 and held it in 4 quarters. The position peaked at $9K in Q4 2021. 312 funds tracked by Wall St. Rank hold ARKG as of Q3 2022.

  • Curi Wealth Management reported no remaining ARK Genomic Revolution ETF position as of Q3 2022 after selling out during the quarter.
  • Curi Wealth Management sold 159 ARK Genomic Revolution ETF shares in Q3 2022, an estimated $5K.
  • Curi Wealth Management first reported a position in ARK Genomic Revolution ETF in Q4 2020 and held it in 4 quarters.
  • Curi Wealth Management's ARK Genomic Revolution ETF position peaked at $9K in Q4 2021.
  • 312 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2022.

Based on Curi Wealth Management's 13F filing for Q3 2022, filed 8 Nov 2022.